This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, National Institute of Health and Medical Research. Active years: 2017-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 3,697 
1 out of 1,853 
Years Active: 2017-2023
Title: Innovations of Lina Li: Pioneering Adeno-Associated Virus Technologies
Introduction
Lina Li is an accomplished inventor based in Potomac, MD, specializing in groundbreaking adeno-associated virus (AAV) technologies. With two patents to her name, her work demonstrates significant contributions to the fields of gene therapy and molecular biology.
Latest Patents
Lina Li’s latest patents showcase her innovative approach to AAV technologies. The first patent, titled "Closed-ended, linear, duplex adenoassociated virus DNA, and uses thereof," details closed-ended linear duplex (CELID) DNA molecules and recombinant AAV particles. This work includes methods for producing these molecules and particles, as well as exploring their therapeutic applications. The second patent, "Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery," describes an isolated linear nucleic acid molecule composed of AAV inverted terminal repeats. Notably, this nucleic acid molecule can be administered to a host repeatedly without triggering an immune response. It also outlines methods for producing and purifying this nucleic acid molecule for therapeutic purposes.
Career Highlights
Throughout her career, Lina Li has worked with prestigious organizations such as the United States Department of Health and Human Services and the Institut National de la Santé et de la Recherche Médicale. Her experiences at these institutions have significantly contributed to her expertise in the field of gene therapy.
Collaborations
Lina has collaborated with distinguished colleagues like Robert Michael Kotin and Luis Garcia, further enhancing the impact of her research. These collaborations have fostered innovation and the advancement of new technologies in the area of AAV applications.
Conclusion
Lina Li's contributions to the field of gene therapy through her patents on adeno-associated virus technologies reflect her innovative spirit and commitment to advancing medical science. As she continues her work, her inventions are poised to have a lasting impact on therapeutic approaches to genetic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile